WALTHAM, Mass., May 19, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, is proud to congratulate co-founder, President and COO Dr. Mary Lynne Hedley on being named the Life Science “Entrepreneur of the Year” by the New England Venture Capital Association. The 2016 NEVY Awards celebrate New England’s Life Science and Tech communities.
The nominees for “Entrepreneur of the Year” in the Life Science space were recognized for their game-changing companies that inspire people.
This year’s nominees were selected by an academy of judges composed of last year’s winners, experts in the technology and life science industries and Boston’s industry influencers and experts who have made a major impact on the city’s entrepreneurial and venture capital landscape.
About the New England Venture Capital Association
The NEVCA is the premier organization for venture capital investors in New England. It strives to keep Boston competitive by championing the community’s top emerging and proven venture backed companies, and making sure Boston students know about the many opportunities presented by such a thriving startup community. Its ultimate goal is to promote economic growth and entrepreneurship throughout the region. With more than 800+ venture capital professionals from 80+ firms, its members collectively manage more than $50 billion in capital.
Follow @NewEnglandVC on Twitter (#NEVYs16), visit www.newenglandvc.org/ or go to the NEVCA’s Facebook page to learn more.
TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients by acquiring, developing and commercializing safer and more effective therapeutics. For more information, visit www.tesarobio.com.
CONTACT: TESARO Investor/Media Contact: Jennifer Davis Sr. Director, Corporate Development & Investor Relations +1.781.325.1116 or firstname.lastname@example.org